Prognostic significance of genetic biomarkers in isocitrate dehydrogenase‐wild‐type lower‐grade glioma: the need to further stratify this tumor entity – a meta‐analysis - Vuong, H. G.; Tran, T. T. K.; Ngo, H. T. T.; Pham, T. Q.; Nakazawa, T.; Fung, K.‐M.; Hassell, L.; Katoh, R.; Kondo, T. (European journal of neurology, 2019)
Keywords: Amplification; astrocytoma; ATRX; Biomarkers; Brain tumors; CDKN2A; Chromosome 10; Chromosome 7; Confidence intervals; Dehydrogenase; Dehydrogenases; EGFR; Epidermal growth factor receptors; Genetic analysis; Genetic markers; Glioma; grade II; grade III; H3F3A; Isocitrate dehydrogenase; lower‐grade glioma; Medical prognosis; Meta-analysis; Mutation; oligodendroglioma; overall survival; Prognosis; review; TERT; Tumors; isocitrate dehydrogenase; oligodendroglioma; CDKN2A; ATRX; H3F3A; meta-analysis; prognosis; EGFR; grade III; TERT; astrocytoma; lower-grade glioma; review; overall survival; grade II